Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Updated ...

AZ is testing Farxiga for HFpEF as well, as are its main rivals Eli Lilly and Boehringer Ingelheim with their SGLT2 drug Jardiance (empagliflozin), with results due in the next year or so.

Meanwhile, like most chronic diseases, type 2 diabetes is treated with drugs, including the newly approved Jardiance ... when she was examining T1D in rat models. In her research, she found ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

The patented medicine, sold as Jardiance, can cost up to Rs 71 per tablet. This is likely to come down to as little as Rs 10-11 per tablet. Consequently, the medicine is then likely to become more ...

Large-cap stocks are stocks issued by corporations that have major influence over the economy. The “cap” in large-cap refers to the company’s “market capitalization,” which is equal to ...

Indian startups raised a total of $1.65 billion (about Rs 14,418 crore) in funding at a median … As per Traxcn data, 16 IPOs were listed in Feb 2025, with a $26.5M median market cap; notable … Mumbai ...

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

Get the full experience! Unlock access to all videos with the Unlimited Trains.com Membership.